We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBK:CRYPTOCAPMarket Cap CBK, $ Analysis

Data as of 2026-06-17 - not real-time

$30.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Commercial Bancgroup, Inc. (CBK) is trading comfortably above its 20‑day, 50‑day and 200‑day simple moving averages, confirming a bullish trend on the price chart. Technical momentum is reinforced by a bullish MACD crossover and an RSI hovering around the mid‑60s, suggesting continued upside but also caution as it nears overbought levels. Support at $27.25 provides a downside cushion, while the nearest resistance near $31.67 caps short‑term gains.
Fundamentally, the stock appears undervalued – the DCF fair value of roughly $36 exceeds the current market price of $30.69 and the trailing P/E of 11 is well below the industry average of 17. Operating efficiency is strong with a 55% operating margin and a 42% profit margin, and the balance sheet is solid with cash exceeding debt. Although CBK does not pay a dividend, its low beta (0.41) and moderate 30‑day volatility (~21%) point to a relatively stable risk profile, making it an attractive candidate for investors seeking value‑oriented exposure in the regional banking sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price above key moving averages indicating bullish momentum
  • Bullish MACD and RSI in the upper-mid range supporting short‑term upside
  • Support level at $27.25 provides downside protection

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~10% upside potential
  • P/E ratio materially lower than industry peers
  • Strong operating margins and solid ROE underpin earnings stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and moderate volatility indicate defensive characteristics
  • Robust cash position relative to debt reduces financial risk
  • Undervalued valuation metrics provide margin of safety for long‑haul investors

Key Metrics & Analysis

Financial Health

Revenue Growth5.30%
Profit Margin41.77%
P/E Ratio11.0
ROE14.64%
ROA1.65%
P/B Ratio1.4
Op. Cash Flow$38.4M
Industry P/E17.1

Technical Analysis

TrendBullish
RSI65.0
Support$27.25
Resistance$31.67
MA 20$29.59
MA 50$28.96
MA 200$26.21
MACDBullish
VolumeStable
Fear & Greed Index92.27

Valuation

Fair Value$36.15
Target Price$34.00
Upside/Downside10.79%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.41
Volatility20.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.